| Literature DB >> 31870292 |
Georgios A Kyritsis1,2, Antonios A Augustinos1, Spyridon Ntougias3, Nikos T Papadopoulos2, Kostas Bourtzis4, Carlos Cáceres1.
Abstract
BACKGROUND: Insect species have established sophisticated symbiotic associations with diverse groups of microorganisms including bacteria which have been shown to affect several aspects of their biology, physiology, ecology and evolution. In addition, recent studies have shown that insect symbionts, including those localized in the gastrointestinal tract, can be exploited for the enhancement of sterile insect technique (SIT) applications against major insect pests such as the Mediterranean fruit fly (medfly) Ceratitis capitata. We previously showed that Enterobacter sp. AA26 can be used as probiotic supplement in medfly larval diet improving the productivity and accelerating the development of the VIENNA 8 genetic sexing strain (GSS), which is currently used in large scale operational SIT programs worldwide.Entities:
Keywords: Biomass; Ceratitis capitata; Gut microbiota; Nutrients; Probiotic fermenter; Probiotics; Symbiotic bacteria
Mesh:
Year: 2019 PMID: 31870292 PMCID: PMC6929400 DOI: 10.1186/s12866-019-1651-z
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Experimental plan followed for the estimation of Enterobacter sp. AA26 potential as protein source substitute
Diet formulas used to evaluate the potential of brewer’s yeast replacement with Enterobacter sp. AA26 in medfly larval diet
| Ingredients | Diet formulas | |||
|---|---|---|---|---|
| Control | 7% Yeast | 7% Bacteria | 3.5% Yeast + 3.5% Bacteria | |
| – | – | 70 g | 35 g | |
| Brewer’s Yeast | – | 70 g | – | 35 g |
| Corncob | 2.0 g | – | 2.0 g | 1.0 g |
| Carrot powder | 150 g | 150 g | 150 g | 150 g |
| HCL | 8.0 ml | 8.0 ml | 8.0 ml | 8.0 ml |
| Na Benzoate | 2.5 ml | 2.5 ml | 2.5 ml | 2.5 ml |
| Nipagin | 2.0 g | 2.0 g | 2.0 g | 2.0 g |
| Water | 770 ml | 770 ml | 770 ml | 770 ml |
Fig. 2Immature stages survival (P: pupae recovery, A: adult recovery)
Fig. 3Adult sex ratio determination
Fig. 4Egg to pupa developmental duration of the four protein source treatments
Brewer’s yeast replacement with Enterobacter sp. AA26 biomass and egg to pupa developmental duration
| Treatment | N | Mean (days) ± SE | Kaplan-Meier / log-rank (Mantel-Cox) |
|---|---|---|---|
| Males | |||
| 7% Y | 331 | 12.21 ± 0.041 | 7% Y vs 3.5% Y + 3.5% B: x2 = 289.85, |
| 7% B | 358 | 10.65 ± 0.039 | 7% B vs 3.5% Y + 3.5% B: x2 = 81.48, |
| 3.5% Y + 3.5% B | 375 | 11.12 ± 0.036 | 7% Y vs 7% B: x2 = 422.73, P < 0.001 |
| Control | 208 | 21.72 ± 0.171 | Control vs 3.5% Y + 3.5% B: x2 = 585.11, P < 0.001 |
| Control vs 7% Y: x2 = 545.19, P < 0.001 | |||
| Control vs 7% B: x2 = 546.65, P < 0.001 | |||
| Females | |||
| 7% Y | 311 | 13.30 ± 0.055 | 7% Y vs 3.5% Y + 3.5% B: x2 = 69.55, P < 0.001 |
| 7% B | 327 | 12.28 ± 0.058 | 7% B vs 3.5% Y + 3.5% B: x2 = 11.12, |
| 3.5% Y + 3.5% B | 297 | 12.56 ± 0.061 | 7% Y vs 7% B: x2 = 131.65, P < 0.001 |
| Control | 94 | 24.94 ± 0.276 | Control vs 3.5% Y + 3.5% B: x2 = 309.37, P < 0.001 |
| Control vs 7% Y: x2 = 321.70, P < 0.001 | |||
| Control vs 7% B: x2 = 325.32, P < 0.001 | |||
Fig. 5Pupa stage developmental duration of the four protein source treatments
Brewer’s yeast replacement with Enterobacter sp. AA26 biomass and pupal stage duration
| Treatment | N | Mean (days) ± SE | Kaplan-Meier / log-rank (Mantel-Cox) |
|---|---|---|---|
| Males | |||
| 7% Y | 302 | 12.11 ± 0.018 | 7% Y vs 3.5% Y + 3.5% B: x2 = 27.27, P < 0.001 |
| 7% B | 319 | 12.59 ± 0.027 | 7% B vs 3.5% Y + 3.5% B: x2 = 65.77, P < 0.001 |
| 3.5% Y + 3.5% B | 345 | 12.28 ± 0.024 | 7% Y vs 7% B: x2 = 154.99, P < 0.001 |
| Control | 111 | 13.04 ± 0.056 | Control vs 3.5% Y + 3.5% B: x2 = 134.06, P < 0.001 |
| Control vs 7% Y: x2 = 203.71, P < 0.001 | |||
| Control vs 7% B: x2 = 53.41, P < 0.001 | |||
| Females | |||
| 7% Y | 283 | 12.52 ± 0.029 | 7% Y vs 3.5% Y + 3.5% B: x2 = 14.98, P < 0.001 |
| 7% B | 295 | 12.85 ± 0.023 | 7% B vs 3.5% Y + 3.5% B: x2 = 21.01, P < 0.001 |
| 3.5% Y + 3.5% B | 273 | 12.68 ± 0.029 | 7% Y vs 7% B: x2 = 69.85, P < 0.001 |
| Control | 41 | 13.34 ± 0.075 | Control vs 3.5% Y + 3.5% B: x2 = 55.49, P < 0.001 |
| Control vs 7% Y: x2 = 71.87, P < 0.001 | |||
| Control vs 7% B: x2 = 46.08, P < 0.001 | |||
Fig. 6Total duration of immature stages (egg to adult) of the four protein source treatments
Brewer’s yeast replacement with Enterobacter sp. AA26 biomass and Immature stages developmental duration
| Treatment | N | Mean (days) ± SE | Kaplan-Meier / log-rank (Mantel-Cox) |
|---|---|---|---|
| Males | |||
| 7% Y | 302 | 24.25 ± 0.044 | 7% Y vs 3.5% Y + 3.5% B: x2 = 204.43, P < 0.001 |
| 7% B | 319 | 23.14 ± 0.039 | 7% B vs 3.5% Y + 3.5% B: x2 = 7.28, |
| 3.5% Y + 3.5% B | 345 | 23.29 ± 0.037 | 7% Y vs 7% B: x2 = 252.11, P < 0.001 |
| Control | 111 | 34.17 ± 0.225 | Control vs 3.5% Y + 3.5% B: x2 = 381.59, P < 0.001 |
| Control vs 7% Y: x2 = 356.90, P < 0.001 | |||
| Control vs 7% B: x2 = 349.70, P < 0.001 | |||
| Females | |||
| 7% Y | 283 | 25.66 ± 0.053 | 7% Y vs 3.5% Y + 3.5% B: x2 = 56.02, P < 0.001 |
| 7% B | 295 | 24.94 ± 0.049 | 7% B vs 3.5% Y + 3.5% B: x2 = 3.15, |
| 3.5% Y + 3.5% B | 273 | 25.05 ± 0.054 | 7% Y vs 7% B: x2 = 88.03, P < 0.001 |
| Control | 41 | 38.51 ± 0.383 | Control vs 3.5% Y + 3.5% B: x2 = 162.49, P < 0.001 |
| Control vs 7% Y: x2 = 165.96, P < 0.001 | |||
| Control vs 7% B: x2 = 176.98, P < 0.001 | |||
Fig. 7Males’ and females’ pupal weight of the flies fed on the three different protein source diets (m: males, f: females). Columns marked on the top with the same letter are not significantly different (P > 0.05)
Fig. 8Females’ fecundity of the flies fed on the three protein source diets
Fig. 9Flight ability of the flies fed on the three protein source diets (m: males, f: females)
Fig. 10Survival under stress conditions of males and females on the three protein source diets (m: males, f: females)
Fig. 11Mating competitiveness of males fed on the three protein source diets